We are live on ! Find out more
DA

Duality Advisers Portfolio holdings

AUM $1.01B
1-Year Est. Return 14.52%
This Fund
S&P 500
This Quarter Est. Return
+2.98%
1 Year Est. Return
+14.52%
3 Year Est. Return
-18.25%
5 Year Est. Return
10 Year Est. Return
AUM
$883M
AUM Growth
+$4.32M
Cap. Flow
+$28.2M
Cap. Flow %
3.19%
Top 10 Hldgs %
6.05%
Holding
818
New
257
Increased
132
Reduced
138
Closed
290

Top Buys

Rank Stock Value
1
FRC
First Republic Bank
FRC
+$19.9M
2
DOC icon
Healthpeak Properties
DOC
+$5.97M
3
CI icon
Cigna
CI
+$5.9M
4
PFE icon
Pfizer
PFE
+$5.61M
5
PACW
PacWest Bancorp
PACW
+$5.61M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$5.39M
2
RMD icon
ResMed
RMD
+$5.36M
3
MRSH
Marsh
MRSH
+$5.32M
4
AJG icon
Arthur J. Gallagher & Co
AJG
+$5.31M
5
AAPL icon
Apple
AAPL
+$5.25M

Sector Composition

Rank Sector Weight
1 Technology 17.44%
2 Healthcare 14.99%
3 Financials 14.33%
4 Industrials 13.82%
5 Consumer Discretionary 12.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLF icon
301
Sun Life Financial
SLF
$46B
$985K 0.11%
+21,090
New +$1.02M
MO icon
302
Altria Group
MO
$122B
$984K 0.11%
22,063
-93,688
-81% -$4.31M
AEP icon
303
American Electric Power
AEP
$72.7B
$978K 0.11%
10,752
+5,702
+113% +$522K
MATX icon
304
Matsons
MATX
$6.22B
$976K 0.11%
+16,352
New +$1.05M
RH icon
305
RH
RH
$3.4B
$971K 0.11%
+3,987
New +$1.16M
BOX icon
306
Box
BOX
$4.18B
$962K 0.11%
+35,901
New +$1.08M
NVCR icon
307
NovoCure
NVCR
$1.97B
$961K 0.11%
15,986
-14,994
-48% -$1.2M
WAT icon
308
Waters Corp
WAT
$36.4B
$958K 0.11%
+3,095
New +$1M
MDRX
309
DELISTED
Veradigm Inc. Common Stock
MDRX
$958K 0.11%
73,433
+45,256
+161% +$733K
VICR icon
310
Vicor
VICR
$9.41B
$954K 0.11%
20,328
+5,471
+37% +$303K
ABCL icon
311
AbCellera Biologics
ABCL
$1.6B
$953K 0.11%
+126,388
New +$1.15M
VAC icon
312
Marriott Vacations Worldwide
VAC
$3.4B
$947K 0.11%
7,023
-4,209
-37% -$625K
CYTK icon
313
Cytokinetics
CYTK
$10.9B
$931K 0.11%
+26,469
New +$1.08M
CRS icon
314
Carpenter Technology
CRS
$28.8B
$926K 0.1%
20,684
+4,066
+24% +$185K
MCHP icon
315
Microchip Technology
MCHP
$42.3B
$919K 0.1%
+10,975
New +$875K
AMGN icon
316
Amgen
AMGN
$203B
$919K 0.1%
+3,802
New +$933K
ESI icon
317
Element Solutions
ESI
$9.22B
$916K 0.1%
47,425
-25,372
-35% -$501K
ROKU icon
318
Roku
ROKU
$21.2B
$910K 0.1%
13,826
-33,455
-71% -$1.96M
MTD icon
319
Mettler-Toledo International
MTD
$27B
$868K 0.1%
567
+58
+11% +$87.1K
AMT icon
320
American Tower
AMT
$77.7B
$860K 0.1%
+4,207
New +$883K
FSLR icon
321
First Solar
FSLR
$22.1B
$843K 0.1%
+3,875
New +$707K
A icon
322
Agilent Technologies
A
$38.9B
$838K 0.09%
6,058
-10,287
-63% -$1.5M
AVA icon
323
Avista
AVA
$3.43B
$837K 0.09%
+19,711
New +$816K
PGNY icon
324
Progyny
PGNY
$2.47B
$827K 0.09%
25,749
-25,979
-50% -$858K
SQM icon
325
Sociedad Química y Minera de Chile
SQM
$19.6B
$826K 0.09%
10,196
+4,270
+72% +$368K

Similar funds

Duality Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, Duality Advisers held 818 positions worth $883M, up 0.49% from $879M the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Duality Advisers deployed $28.2M of net new capital in Q1 2023, opening 257 new positions and adding to 132 existing holdings. Its largest new stake was First Republic Bank: 194,134 shares worth $2.72M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Corteva, an estimated $4.44M trimmed.

  • Duality Advisers's largest Q1 2023 buy was First Republic Bank: 194,134 shares worth $2.72M.
  • Duality Advisers added most to PacWest Bancorp in Q1 2023, an estimated $5.61M increase.
  • Duality Advisers's biggest Q1 2023 reduction was Corteva, cutting an estimated $4.44M.
  • Duality Advisers fully exited Walt Disney in Q1 2023, selling an estimated $5.39M.
  • Duality Advisers's ten largest holdings make up 6% of its $883M portfolio in Q1 2023.
  • Duality Advisers opened 257 new positions and closed 290 in Q1 2023.
  • Duality Advisers's portfolio value rose 0.49% quarter-over-quarter to $883M.

Based on Duality Advisers's 13F filing for Q1 2023, filed 27 Jun 2023.